IPO - Empro Group Inc.

Form Type: F-1/A

Filing Date: 2025-05-27

Corporate Action: Ipo

Type: New

Accession Number: 000164117225012431

Filing Summary: Empro Group Inc. is conducting an initial public offering (IPO) of 1,250,000 ordinary shares with a proposed price range of $4.00 to $4.50 per share. The company has established a presence in the beauty and healthcare sectors and intends to list its shares under the symbol 'EMPG' on the Nasdaq Capital Market. Empro Group operates through its wholly-owned subsidiary, EMP Solution Sdn. Bhd., and plans to expand its product lines to include cosmetics and skincare while leveraging exclusive distributorships with original equipment manufacturers across Southeast Asia and Europe. The company’s financial performance has shown fluctuations, with total revenues increasing in 2024 after a decrease in 2023 linked to the COVID-19 pandemic. The company has also detailed its competitive advantages, growth strategies, and various risks associated with its operations, including market competition and dependency on the continued popularity of its products. Mr. Yeoh Chee Wei, the founder and CEO, is expected to retain significant ownership post-offering, qualifying the company as a 'controlled company' under Nasdaq rules.

Form Type: F-1/A

Filing Date: 2025-05-22

Corporate Action: Ipo

Type: New

Accession Number: 000164117225012016

Filing Summary: Empro Group Inc. is filing an amendment to its registration statement for an initial public offering (IPO) of 1,250,000 Ordinary Shares, with an expected price between $4.00 and $4.50 per share. The offering is being made on a firm commitment basis, with underwriters entitled to purchase an additional 187,500 shares to cover over-allotments. The company projects total gross proceeds of approximately $5 million at the midpoint offering price, and it will be listing on the Nasdaq Capital Market under the symbol 'EMPG'. Yeoh Chee Wei, the company's founder and CEO, will hold approximately 64.7% of shares post-offering. Empro Group operates through its subsidiary in Malaysia, distributing healthcare and beauty products across the ASEAN region and Europe. The company has experienced fluctuations in revenue and profitability, reflective of market dynamics, particularly in the COVID-19 impacted healthcare segment. Furthermore, as an emerging growth company, it will benefit from reduced reporting requirements. The registration statement must be effective before the company can commence public sales.

Form Type: F-1/A

Filing Date: 2025-05-20

Corporate Action: Ipo

Type: New

Accession Number: 000164117225011736

Filing Summary: Empro Group Inc. is filing an amendment to their registration statement on Form F-1 for the initial public offering (IPO) of 1,250,000 ordinary shares at an expected price range of $4.00 to $4.50 per share. This represents the first public offering of their shares, as prior to this, no public market existed for these shares. The company, controlled by founder Yeoh Chee Wei, will potentially maintain about 64.7% ownership post-offering, categorizing it as a controlled company subject to certain Nasdaq exemptions regarding corporate governance. The document highlights their operational history in beauty and healthcare, including successful product lines and a well-established distribution network in ASEAN and European markets. Their current financial performance shows fluctuating revenues, with a notable increase in cosmetics and skincare revenue in the recent fiscal year, although they faced challenges from decreased demand in their healthcare segment post-COVID-19. The company is categorized as an emerging growth company, which subjects it to reduced reporting requirements.

Form Type: F-1/A

Filing Date: 2025-05-09

Corporate Action: Ipo

Type: New

Accession Number: 000164117225009500

Filing Summary: Empro Group Inc. is conducting its initial public offering of 1,250,000 Ordinary Shares at an expected price range of $4.00 to $4.50 per share. As of the filing date, there has been no previous public market for these shares. Yeoh Chee Wei, the founder and CEO, is projected to beneficially own approximately 64.7% of the shares after the offering, making the company a 'controlled company'. The offering is expected to yield total gross proceeds of around $5 million, with underwriters receiving a discount of 7.5% per share. The business primarily operates through its wholly-owned subsidiary, EMP Solution Sdn. Bhd., focusing on the healthcare and beauty product markets in the ASEAN region and Europe. Future growth strategies include the expansion of product lines, entering new markets, and investing in technology. The company is categorized as an 'emerging growth company' and has reserved the symbol 'EMPG' for the Nasdaq Capital Market listing. There are significant risks associated with this investment, including market competition and product demand fluctuations.

Form Type: F-1/A

Filing Date: 2025-03-31

Corporate Action: Ipo

Type: New

Accession Number: 000164117225001581

Filing Summary: Empro Group Inc. is conducting its initial public offering (IPO) of 1,250,000 ordinary shares with a proposed price range of $4.00 to $4.50 per share. The company is seeking to list its shares on the Nasdaq Capital Market under the symbol 'EMPG'. The registration statement was filed with the SEC on March 31, 2025, indicating the company is an emerging growth entity. Following the IPO, the founder Yeoh Chee Wei is expected to maintain significant ownership, which categorizes Empro as a controlled company under Nasdaq rules. The company operates through its Malaysian subsidiary, EMP Solution Sdn. Bhd., primarily in the beauty and healthcare sectors, and boasts a diverse distribution network in the ASEAN region and Europe. The document outlines the company's competitive strengths, growth strategies, historical financial performance, and risk factors associated with investing in their shares. The approval of the SEC is noted as pending, which is standard in such filings.

Form Type: F-1/A

Filing Date: 2025-02-07

Corporate Action: Ipo

Type: New

Accession Number: 000149315225005437

Filing Summary: Empro Group Inc. is launching an initial public offering (IPO) of 1,250,000 Ordinary Shares with an expected price range of $4.00 to $4.50 per share. The company has reserved the symbol 'EMPG' for listing on the Nasdaq Capital Market. This IPO follows a history of operations in the beauty and healthcare sector, with significant expansion plans across ASEAN and Europe. The company is emerging from a dynamic operational history, originating from a focus on beauty products and gradually encompassing healthcare solutions. The leadership of Yeoh Chee Wei, the founder and CEO, places importance on expanding product offerings, which includes the introduction of new brands targeting various market segments. Despite experiencing a net loss for the fiscal year ended December 31, 2023, attributed to decreased demand for their healthcare products post-COVID-19, Empro anticipates leveraging its established B2B relationships to recover and grow. Risk factors include competitive pressures, operational history limitations, reliance on third-party platforms for sales, and economic fluctuations in key markets.

Form Type: F-1/A

Filing Date: 2025-01-22

Corporate Action: Ipo

Type: New

Accession Number: 000149315225003202

Filing Summary: Empro Group Inc. is conducting its initial public offering of 1,250,000 Ordinary Shares at an estimated price range of $4.00 to $4.50 per share. This offering is being managed on a firm commitment basis, where underwriters must purchase all shares offered. The company, incorporated in the Cayman Islands, plans to list on the Nasdaq Capital Market under the symbol 'EMPG'. Yeoh Chee Wei, the CEO, will own approximately 64.7% of the company post-offering, making Empro Group a 'controlled company' under Nasdaq rules, although they do not intend to rely on the exemptions provided for controlled companies. The need for listing on a national exchange is stipulated as a condition for closing this offering. The registration statement is an amendment and represents a move towards public trading after a substantial operating history in the healthcare and beauty sectors, predominantly through its Malaysian subsidiary, EMP Solution. The company has faced a decline in revenue attributed to decreased demand for medical masks post-COVID-19, posing a risk to future cash flows. This prospectus outlines the company's strategic direction and highlights the potential risks of investing in their shares.